Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Myopic patients and eyes with macular disorders: a new indication for MIOLs?

Search Title by author or title

Session Details

Session Title: Pseudophakic IOLs: Multifocal I

Session Date/Time: Sunday 08/10/2017 | 08:00-10:00

Paper Time: 09:14

Venue: Room 2.1

First Author: : S.Nienhaus GERMANY

Co Author(s): :    T. Tandogan   P. Hagen   G. Auffarth   D. Breyer   K. Klabe   H. Kaymak     

Abstract Details

Purpose:

The performance of a new developed rotation symmetrically refractive high add (+8D) multifocal IOL (MIOL) has not been been investigated in patients with maculopathy or myopia yet. We present here our first results with this lens (case series).

Setting:

Internationale Innovative Ophthalmochirurgie Düsseldorf, Germany; International Vision Correction Research Network, Germany

Methods:

We analyzed 10 patients retrospectively: Myopic eyes with and without a maculopathy The following parameters were evaluated: metamorphopsia, subjective refraction, visual acuity at different distances and patient satisfaction. Halo and glare was assessed with a computer based system. Additionally a patient questionnaire was evaluated.

Results:

The postoperative measurements of the visual acuity with the MIOL with higher near addition was on average 0.8 in myopic eyes and 0.5 with maculopathy. The defocus curve showed a binocular profile with a maximum at 0 D and 6 D. Halo and glare were either absent or described as undisturbing. A reading distance of 20 cm was well tolerated. Subjective reading speed was satisfying for all patients compared to the preoperative status.

Conclusions:

Our analysis indicates, that implantation of MIOL with high add can be an option in myopic patients or patients with a maculopathy. The short reading distance was very well accepted by the patients. Furthermore, the implantation offers for the patient a magnifying effect for the future, when macula function drops.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a competing company

Back to previous